Live from the NIH registry
Studies recruiting near Knoxville right now
Top 25 of 231 recruiting studies, sorted by proximity — each links to its official registry page
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
University of Tennessee - Knoxville — Knoxville, Tennessee (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
East Tennessee Childrens Hospital — Knoxville, Tennessee (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Phase 3
Interventional 641 participants sought
University of Tennessee Medical Center — Knoxville, Tennessee (1.7 mi)
· Sponsor: Janssen Research & Development, LLC
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
University of Tennessee Medical Center — Knoxville, Tennessee (1.7 mi)
· Sponsor: Regeneron Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University Telemedicine — Knoxville, Tennessee (1.7 mi)
· Sponsor: Sameek Roychowdhury
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Malignant Glioma
Phase 1, Phase 2
Interventional 132 participants sought
East Tennessee Childrens Hospital — Knoxville, Tennessee (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Knoxville, Tennessee (1.7 mi)
· Sponsor: AstraZeneca
AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDE
Hernia
N/A
Interventional 240 participants sought
University of Tennessee Medical Center — Knoxville, Tennessee (1.7 mi)
· Sponsor: Tissium
Registry Study for Radiation Therapy Outcomes
Neoplasms
N/A
Observational 50,000 participants sought
Thompson Proton Center — Knoxville, Tennessee (1.7 mi)
· Sponsor: Proton Collaborative Group
EBT Fruit and Vegetable Prescription
Childhood Obesity, Obesity
N/A
Interventional 30 participants sought
Cherokee Health Systems, Dameron Avenue Pedatrics — Knoxville, Tennessee (1.7 mi)
· Sponsor: The University of Tennessee, Knoxville
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
University of Tennessee Medical Center Knoxville — Knoxville, Tennessee (1.7 mi)
· Sponsor: Amgen
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Menstrual Migraine
Phase 3
Interventional 723 participants sought
Alliance for Multispecialty Research, LLC — Knoxville, Tennessee (1.7 mi)
· Sponsor: Pfizer
ColoCare Study - Colorectal Cancer Cohort
Colorectal Cancer
N/A
Observational 5,000 participants sought
University of Tennessee — Knoxville, Tennessee (1.7 mi)
· Sponsor: University of Utah
Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD
COPD Exacerbation
Phase 4
Interventional 60 participants sought
University of Tennessee Medical Center — Knoxville, Tennessee (1.7 mi)
· Sponsor: University of Tennessee Graduate School of Medicine
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab
Generalized Myasthenia Gravis, gMG
Phase 4
Interventional 75 participants sought
Research Site — Knoxville, Tennessee (1.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 120 participants sought
University of Tennessee Medical Center — Knoxville, Tennessee (1.7 mi)
· Sponsor: Pfizer
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Barrett Esophagus, Barretts Esophagus With Dysplasia
N/A
Interventional 2,298 participants sought
Gastrointestinal Associates, PC — Knoxville, Tennessee (1.7 mi)
· Sponsor: University of Colorado, Denver
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
PMG Research of Knoxville /ID# 256854 — Knoxville, Tennessee (1.7 mi)
· Sponsor: AbbVie
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
University of Tennessee - Knoxville — Knoxville, Tennessee (1.7 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
Obesity
Phase 1
Interventional 124 participants sought
MBX Biosciences Investigational Site — Knoxville, Tennessee (1.7 mi)
· Sponsor: MBX Biosciences
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
East Tennessee Childrens Hospital — Knoxville, Tennessee (1.7 mi)
· Sponsor: National Cancer Institute (NCI)
Evaluating Health Outcomes of AI-Based Fitness Wearables and App Programs in Older Adults Living Alone With Cognitive Decline
Older Adults With Cognitive Decline, Older Adults
N/A
Interventional 64 participants sought
University of Tennessee — Knoxville, Tennessee (1.7 mi)
· Sponsor: The University of Tennessee, Knoxville
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer
Phase 3
Interventional 1,410 participants sought
Tennessee Cancer Specialists Dowell Springs location — Knoxville, Tennessee (1.7 mi)
· Sponsor: Pfizer
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Atherosclerotic Cardiovascular Disease, Overweight
Phase 3
Interventional 12,800 participants sought
Accellacare of Knoxville — Knoxville, Tennessee (1.7 mi)
· Sponsor: Amgen
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction
Phase 3
Interventional 5,056 participants sought
Cardiovascular Research of Knoxville North Knoxville Medical Center — Powell, Tennessee (6.2 mi)
· Sponsor: Amgen